We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

103 hedge funds and large institutions have $87.5M invested in Sanofi Contingent Value Rights in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

8% more capital invested

Capital invested by funds: $80.8M → $87.5M (+$6.65M)

1% less funds holding

Funds holding: 104 → 103 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

Holders
103
Holders Change
-1
Holders Change %
-0.96%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
9
Increased
11
Reduced
16
Closed
10
Calls
$17M
Puts
–
Net Calls
+$17M
Net Calls Change
+$1.83M

Top Buyers

Rank Fund Capital Flow
1
JCI
Jet Capital Investors
New York
+$997K
2
SCM
Stonehill Capital Management
New York
+$243K
3
BHMP
Bardin Hill Management Partners
New York
+$74.8K
4
HCM
Highbridge Capital Management
New York
+$16.9K
5
Goldman Sachs
Goldman Sachs
New York
+$9.35K

Top Sellers

Rank Fund Capital Flow
1
DAM
DLD Asset Management
New York
-$335K
2
CL
CSS LLC
Illinois
-$154K
3
Citadel Advisors
Citadel Advisors
Florida
-$70K
4
TL
TowerView LLC
New York
-$56.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$61K -$130 -242 -0.2%
GI
27
GAMCO Investors
Connecticut
$35K – – –
UBS Group
28
UBS Group
Switzerland
$29K -$14K -26,013 -34%
Royal London Asset Management
29
Royal London Asset Management
United Kingdom
$25K – – –
ZIG
30
Zuckerman Investment Group
Illinois
$23K – – –
Morgan Stanley
31
Morgan Stanley
New York
$16K +$42 +78 +0.3%
Bank of America
32
Bank of America
North Carolina
$14K +$3.41K +6,333 +31%
AL
33
Arnhold LLC
New York
$11K -$24.2K -44,917 -70%
Ameriprise
34
Ameriprise
Minnesota
$11K -$3.51K -6,523 -25%
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$9K -$2.77K -5,159 -24%
LPL Financial
36
LPL Financial
California
$9K -$81 -150 -0.9%
CHAM
37
Clear Harbor Asset Management
Connecticut
$9K – – –
HKAM
38
Horizon Kinetics Asset Management
New York
$9K – – –
MC
39
Moors & Cabot
Massachusetts
$9K – – –
FHA
40
Flagship Harbor Advisors
Massachusetts
$8K – – –
RWP
41
RWA Wealth Partners
Massachusetts
$8K – – –
William Blair & Company
42
William Blair & Company
Illinois
$8K – – –
EAM
43
Erste Asset Management
Austria
$6.72K – – –
BIA
44
Biondo Investment Advisors
Pennsylvania
$6K – – –
BlackRock
45
BlackRock
New York
$6K – – –
DA
46
Dillon & Associates
Michigan
$6K – – –
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$4K -$77 -144 -2%
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$4K -$16 -30 -0.5%
CAPTRUST Financial Advisors
49
CAPTRUST Financial Advisors
North Carolina
$4K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$4K – – –
1
2
3 4

GCVRZ Hedge Fund Activity: Q3 2019 in Review

103 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2019, worth a combined $87.5M — up 8.2% from $80.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GCVRZ and 9 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 11 added.

The largest buyer was Jet Capital Investors, adding an estimated $997K. The largest seller was DLD Asset Management, exiting entirely with an estimated $335K sold.

  • 103 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2019, down from 104 in Q2 2019.
  • Funds reported $87.5M of Sanofi Contingent Value Rights stock for Q3 2019, up 8.2% quarter-over-quarter.
  • 9 funds opened new Sanofi Contingent Value Rights positions in Q3 2019 and 10 closed out, a net change of -1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2019 was Jet Capital Investors, an estimated $997K added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2019 was DLD Asset Management, an estimated $335K sold.

Based on aggregated 13F filings for Q3 2019.